CSL Malaysia Biostate? Human Coagulation Factor VIII 250 IU/von Willebrand Factor 500 IU powder for injection vial Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

csl malaysia biostate? human coagulation factor viii 250 iu/von willebrand factor 500 iu powder for injection vial

csl behring australia pty ltd - von willebrand factor, quantity: 500 iu; factor viii, quantity: 250 iu - injection, powder for - excipient ingredients: albumin; sodium chloride; calcium chloride dihydrate; plasma proteins; sodium citrate dihydrate; sucrose; trometamol - biostate is indicated for: - the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von willebrand disease when desmopressin, (ddavp) treatment is ineffective or contraindicated. - the prophylaxis and treatment of non-surgical and surgical bleeding associated with fviii deficiency due to haemophilia a.

CSL New Zealand Biostate Human Coagulation Factor VIII, Freeze-Dried 500 IU, powder for injection Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

csl new zealand biostate human coagulation factor viii, freeze-dried 500 iu, powder for injection

csl behring australia pty ltd - factor viii, quantity: 500 iu; von willebrand factor, quantity: 1000 iu - injection, diluent for - excipient ingredients: water for injections - biostate is indicated for - the treatment and prophylaxis of haemorrhage or surgical bleeding in vwd when desmopressin (ddavp) treatment alone is ineffective or contraindicated - the treatment and prophylaxis of bleeding associated with factor viii deficiency due to haemophilia a.

CSL New Zealand Biostate Human Coagulation Factor VIII, Freeze Dried 500 IU (100IU/mL), powder for injection Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

csl new zealand biostate human coagulation factor viii, freeze dried 500 iu (100iu/ml), powder for injection

csl behring australia pty ltd - factor viii, quantity: 500 iu; von willebrand factor, quantity: 1000 iu - injection, diluent for - excipient ingredients: water for injections - biostate is indicated for - the treatment and prophylaxis of haemorrhage or surgical bleeding in vwd when desmopressin (ddavp) treatment alone is ineffective or contraindicated - the treatment and prophylaxis of bleeding associated with factor viii deficiency due to haemophilia a.

CSL New Zealand Biostate Human Coagulation Factor VIII, Freeze-Dried 250 IU, powder for injection Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

csl new zealand biostate human coagulation factor viii, freeze-dried 250 iu, powder for injection

csl behring australia pty ltd - factor viii, quantity: 250 iu; von willebrand factor, quantity: 500 iu - injection, diluent for - excipient ingredients: water for injections - biostate is indicated for: - the treatment and prophylaxis of haemorrhageor surgical bleeding in vwd when desmopressin (ddavp) treatmentalone is ineffective or contraindicated - the treatment and prophylaxis ofbleeding associated with factor viii deficiency due to haemophilia a.

Dried Factor VIII Fraction type 8Y 500unit powder and solvent for solution for injection vials Միացյալ Թագավորություն - անգլերեն - MHRA (Medicines & Healthcare Products Regulatory Agency)

dried factor viii fraction type 8y 500unit powder and solvent for solution for injection vials

bio products laboratory ltd - factor viii; von willebrand factor - powder and solvent for solution for injection - 500unit ; 1000unit

OPTIVATE 250 International Unit Pdr+Solv for Soln for Inj Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

optivate 250 international unit pdr+solv for soln for inj

bio products laboratory limited - factor viii (antihaemophilic factor), von willebrand factor - pdr+solv for soln for inj - 250 international unit - blood coagulation factors

OPTIVATE 500 International Unit Pdr+Solv for Soln for Inj Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

optivate 500 international unit pdr+solv for soln for inj

bio products laboratory limited - factor viii (antihaemophilic factor), von willebrand factor - pdr+solv for soln for inj - 500 international unit - blood coagulation factors

OPTIVATE 1000 International Unit Pdr+Solv for Soln for Inj Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

optivate 1000 international unit pdr+solv for soln for inj

bio products laboratory limited - factor viii (antihaemophilic factor), von willebrand factor - pdr+solv for soln for inj - 1000 international unit - blood coagulation factors

WILATE 1000 Իսրայել - անգլերեն - Ministry of Health

wilate 1000

dover medical & scientific equipment ltd, israel - factor viii (human); von willebrand factor - powder and solvent for solution for injection - von willebrand factor 1000 iu/vial; factor viii (human) 1000 iu/vial - coagulation factor viii - von willebrand disease (vwd) :prevention and treatment of haemorrhage or surgical bleeding in von willebrand disease (vwd), when desmopressin (ddavp) treatment alone is ineffective or contra-indicated.haemophilia a :treatment and prophylaxis of bleeding in patients with haemophilia a (congenital fviii deficiency).

WILATE 500 Իսրայել - անգլերեն - Ministry of Health

wilate 500

dover medical & scientific equipment ltd, israel - factor viii (human); von willebrand factor - powder and solvent for solution for injection - von willebrand factor 500 iu/vial; factor viii (human) 500 iu/vial - coagulation factor viii - von willebrand disease (vwd) :prevention and treatment of haemorrhage or surgical bleeding in von willebrand disease (vwd), when desmopressin (ddavp) treatment alone is ineffective or contra-indicated.haemophilia a :treatment and prophylaxis of bleeding in patients with haemophilia a (congenital fviii deficiency).